insights_auto
Bakit bumaba ang 603259 6.60%?
Tingnan ang Higit pang Detalyechevron_right
603259:SHA
WuXi AppTec Co Ltd
CN¥144.30
arrow_downward
-6.60%(-10.20) 1D
Okt 16, 3:00:01 PM GMT+8 · CNY
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 603259...
Buksan
CN¥156.94
Mataas
CN¥159.92
Mababa
CN¥139.05
Mkt. cap
447.48B
Avg. na dami
34.02M
Dami
83.61M
Dividend
1.45%
Bawat tatlong buwang dividend
CN¥0.52
Petsa ng ex-dividend
Set 4, 2026
P/E ratio
19.63
Mataas nang 52-wk
CN¥173.60
Mababa nang 52-wk
CN¥87.09
EPS
CN¥7.35
Mga natitirang share
1.05B
Bilang ng mga empleyado
36K
Buksan
CN¥156.94
Mataas
CN¥159.92
Mababa
CN¥139.05
Mkt. cap
447.48B
Avg. na dami
34.02M
Dami
83.61M
Dividend
1.45%
Bawat tatlong buwang dividend
CN¥0.52
Petsa ng ex-dividend
Set 4, 2026
P/E ratio
19.63
Mataas nang 52-wk
CN¥173.60
Mababa nang 52-wk
CN¥87.09
EPS
CN¥7.35
Mga natitirang share
1.05B
Bilang ng mga empleyado
36K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
ad-hoc-news.de
·
8 oras ang nakalipas
WuXi AppTec earns EcoVadis gold: what it means for WuXi AppTec stock
Profile
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe.
Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. It produces a large part of the ingredients used in treatments for illnesses including leukemia, lymphoma, HIV, and obesity. As of 2025, the company reported around 39,000 employees and 6,000 customers. Its clients have included Jiangsu Hengrui, GlaxoSmithKline, AstraZeneca and Pfizer. Wikipedia
Tungkol sa WuXi AppTec Co Ltd
CEOSteve Yang | Ge Li
Mga Empleyado35.6K
ItinatagDis 1, 2000
Headquarters-
Sektor-
Websitewuxiapptec.com.cn